ABUS icon

Arbutus Biopharma

53 hedge funds and large institutions have $207M invested in Arbutus Biopharma in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 8 closing their positions.

Holders
53
Holders Change
+3
Holders Change %
+6%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
15
Reduced
15
Closed
8
Calls
$141K
Puts
$169K
Net Calls
-$28K
Net Calls Change
-$322K
Name Holding Trade Value Shares
Change
Shares
Change %
SIM
51
Sonora Investment Management
Arizona
$124
SM
52
Sabby Management
Florida
-$895K -248,600 Closed
Goldman Sachs
53
Goldman Sachs
New York
-$330K -91,706 Closed
Citadel Advisors
54
Citadel Advisors
Florida
-$52K -14,428 Closed
Ameriprise
55
Ameriprise
Minnesota
-$48K -13,349 Closed
Simplex Trading
56
Simplex Trading
Illinois
-$6K -1,914 Closed
Creative Planning
57
Creative Planning
Kansas
-$4K -1,050 Closed
RFM
58
Royal Fund Management
Florida
-$2K -800 Closed
US Bancorp
59
US Bancorp
Minnesota
-$1K -200 Closed